{"status": "OK", "response": {"docs": [{"type_of_material": "News", "blog": [], "news_desk": "Business/Financial Desk", "lead_paragraph": "As allergy season peaks across much of the country, millions of Americans are paying much more for the medicines they rely on to keep symptoms at bay. This is the first spring in which Claritin, the most popular allergy drug, is available without a prescription. A major health insurer pushed for the change, arguing that it would benefit consumers. But instead, insurers -- and the employers that pay for health insurance themselves -- have so far been the biggest beneficiaries, paying for allergy drugs a fraction of the $1 billion or more that Claritin used to cost them each year.", "headline": {"main": "Claritin's Price Falls, but Drug Costs More"}, "abstract": "Allergy medicine Claritin's price has fallen since it became available without prescription, but consumers who had insurance covering drug often pay more because they pick up full price, instead of just co-payment; month's supply of drug costs about $30, instead of $15 to $20 co-payments that people with health insurance used to pay; lower-priced generic versions of Claritin, made by Schering-Plough Corp, are starting to appear, and that could lower costs; several other popular allergy drugs, including Aventis' Allegra and Pfizer Inc's Zyrtec, are still available only by prescription; many health plans--hoping to induce consumers to switch to over-the-counter Claritin--are increasing co-payments members pay for these drugs, or requiring special request for other drugs from patient's doctor; some health plans are planning to drop almost all coverage for prescription allergy drugs; chart; photo (M)", "print_page": "1", "word_count": 1385, "_id": "4fd22c0d8eb7c8105d7b815e", "snippet": "As allergy season peaks across much of the country, millions of Americans are paying much more for the medicines they rely on to keep symptoms at bay.     This is the first spring in which Claritin, the most popular allergy drug, is available without...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2003/05/08/business/claritin-s-price-falls-but-drug-costs-more.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "organizations", "value": "PFIZER INC"}, {"name": "organizations", "value": "SCHERING-PLOUGH CORP"}, {"name": "organizations", "value": "AVENTIS"}, {"name": "subject", "value": "GENERIC AND BRAND NAME PRODUCTS"}, {"name": "subject", "value": "ZYRTEC (DRUG)"}, {"name": "subject", "value": "HEALTH INSURANCE"}, {"name": "subject", "value": "CLARITIN (DRUG)"}, {"name": "subject", "value": "PRICES (FARES, FEES AND RATES)"}, {"name": "subject", "value": "CONSUMER PROTECTION"}, {"name": "subject", "value": "ALLEGRA (DRUG)"}, {"name": "subject", "value": "ALLERGIES"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Milt", "lastname": "FREUDENHEIM"}], "original": "By MILT FREUDENHEIM"}, "document_type": "article", "pub_date": "2003-05-08T00:00:00Z", "section_name": "Health; Business"}, {"type_of_material": "Summary", "blog": [], "news_desk": "Metropolitan Desk", "lead_paragraph": "INTERNATIONAL A3-11 U.S. Calls for Action On Iran's Nuclear Program The Bush administration, concerned that Iran has accelerated a covert nuclear program, is pressing the International Atomic Energy Agency to declare that the country has violated the Nuclear Nonproliferation Treaty, a finding that could lead to United Nations penalties. A1 A protest by hundreds of Iraqi doctors, nurses and health workers against the American decision to appoint Ali Shnan al-Janabi, a senior Baath Party member, as minister of health indicates concern about the influence of the party that Saddam Hussein used to impose terror. A1", "headline": {"main": "NEWS SUMMARY"}, "abstract": null, "print_page": "2", "word_count": 1013, "_id": "4fd274128eb7c8105d832059", "snippet": "INTERNATIONAL   A3-11    U.S. Calls for Action On Iran's Nuclear Program  The Bush administration, concerned that Iran has accelerated a covert nuclear program, is pressing the International Atomic Energy Agency to declare that the country has...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2003/05/08/nyregion/news-summary-602752.html", "multimedia": [], "subsection_name": null, "keywords": [], "byline": null, "document_type": "article", "pub_date": "2003-05-08T00:00:00Z", "section_name": "New York and Region"}, {"type_of_material": "News", "blog": [], "news_desk": "Business/Financial Desk", "lead_paragraph": "A jury verdict in California may lead to a wave of new asbestos litigation that would greatly increase costs for insurance companies, industry experts and plaintiffs' lawyers said yesterday. On Monday, a jury in a civil trial in Los Angeles concluded that a group of London insurance companies and two American insurers must immediately pay nearly $200 million for claims already filed against the bankrupt Fuller-Austin Insulation Company, as well as those expected to be filed against a trust created by the company.", "headline": {"main": "Asbestos Verdict In California Case Worries Insurers In Other Lawsuits"}, "abstract": "Jury in civil trial in Los Angeles concludes that about 40 British companies, including Lloyd's of London and American companies Stonewall Insurance Co and Highland Insurance Group must pay nearly $200 million for asbestos claims already filed against bankrupt Fuller-Austin Insulation Co, as well as those expected to be filed against trust created by company; industry experts and plantiffs' lawyers say verdict may lead to wave of new asbestos litigation that woujld greatly increase costs for insurance companies; several insurance experts say California verdict underscores need for broad solution that is being negotiated by Congress, Bush administration, insurers, lawyers and corporations that would create national trust to deal with asbestos claims and remove issue from courts (M)", "print_page": "1", "word_count": 1022, "_id": "4fd22c0d8eb7c8105d7b8160", "snippet": "A jury verdict in California may lead to a wave of new asbestos litigation that would greatly increase costs for insurance companies, industry experts and plaintiffs' lawyers said yesterday.     On Monday, a jury in a civil trial in Los Angeles...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2003/05/08/business/asbestos-verdict-in-california-case-worries-insurers-in-other-lawsuits.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "persons", "value": "BUSH, GEORGE W"}, {"name": "glocations", "value": "UNITED STATES"}, {"name": "glocations", "value": "CALIFORNIA"}, {"name": "organizations", "value": "FULLER-AUSTIN INSULATION CO"}, {"name": "organizations", "value": "HIGHLAND INSURANCE GROUP"}, {"name": "organizations", "value": "STONEWALL INSURANCE CO"}, {"name": "organizations", "value": "LLOYD'S OF LONDON"}, {"name": "subject", "value": "SUITS AND LITIGATION"}, {"name": "subject", "value": "LAW AND LEGISLATION"}, {"name": "subject", "value": "ASBESTOS"}, {"name": "subject", "value": "DECISIONS AND VERDICTS"}, {"name": "subject", "value": "BANKRUPTCIES"}, {"name": "subject", "value": "LIABILITY FOR PRODUCTS"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1}], "original": "By JOSEPH B. TREASTER"}, "document_type": "article", "pub_date": "2003-05-08T00:00:00Z", "section_name": "Business"}], "meta": {"hits": 23, "offset": 20, "time": 33}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}